We’d like to thank those who joined us for our webinar on October 16, 2025, and invite everyone to watch it on demand!
Timestamps for Reference
1:40 – Welcome, Kate Moynihan
4:10 – Technology Introduction, Katie McMillan
6:23 – Vision Center Management Software, Dr. Shalinder & Team at Dr. Shroff’s Charity Eye Hospital
15:18 – Pre-School Vision Screening with SPOT, Dr. Manisha Shrestha & Team at Bharatpur Eye Hospital
23:29 – Retinal Imaging in Outreach, Dra. Gabriella Pena at INVIS
29:25 – Pristine 5.0 in Africa, Dr. Tamara Chirambo Nyaka, Malawi
36:30 – Panel Discussion & Questions
Additional Questions
We had some questions we didn’t have time to answer live. If you have comments or additional questions, we’d love to hear from you on this post!
- Does anyone have insight into digital ocular pathology?
Katie: I admit I’ve not researched this topic deeply. Do you mean taking digital images/photographcs of the pathology so that it can be interpreted elsewhere? I’d love to talk more about your use case and questions – please feel free to send an email to kmcmillan@seva.org!
It is quite a futuristic question, and an exciting one. It reminds me of the Zeiss Artevo 800 retina operating microscope which I am looking forward to experiencing. It combines 3D viewing (like the Alcon NGENUITY VS) for improved ergonomics; and has a fully integrated intraoperative OCT (iOCT) for real-time microscopic tissue viewing for both the surgeon and assistant (and others in the room via a screen). It is for both anterior and posterior segment surgeries. I can only imagine the impact It has on surgical and hopefully visual outcomes as well, as it should improve the surgeon’s precision greatly intraoperatively. Additionally, digital images can be shared for consultation while at it. It ought to make teaching much easier as well.
Having said the above as an example, digital ocular pathology would come at a great capital cost to pool images and formulate algorithms for pattern recognition to improve diagnosis, consistency and access to expert opinion. There are data storage issues amongst others. I think the provision by, for example, the Remidio 5.0 fundus camera with its cloud storage for images are baby steps towards digitization and AI assisted patient management.
- What are your tips for making the best use of technology in remote areas, where power and connectivity and staff education may be challenging?
Dr. Manisha: There is a device called arc light, which is battery operated but also has a solar charging option, a very light portable device for fundus examination. I feel teaching the health care personnel at the community level at least for fundal eye reflex screening in children ( at birth, at time of vaccination or when they visit when they are sick) holds significance for detecting amblyogenic risk factors early and then can be referred to eye care facilities.
Katie: We also talked during the live Q&A about supporting systems – uninterruptible power sources, satellite internet, compensation for staff who are trained on critical technologies – that have helped in certain projects.
- How do you organize your documentation (SOPs, technology instructions), and how do you evaluate progress and quality within technology projects?
Katie: For Seva projects, we help with quarterly check-ins that ask about quantitative metrics and offer the opportunity to discuss what went well and where there are challenges. I’ve seen the most successful projects have clear leadership buy-in and they tend to follow common practices. So if you have an SOP for infection control, your retinal camera SOP could be found in a similar spot. That way all staff members have a common understanding of where to look for help.
- How can technology improve the quality of eye care?
Katie: In the SCEH conversation, we talked about how the capturing of data (patients seen, returning patients, outcomes of treatment) was very helpful in sharing with the vision center staff so they could tell what had happened and compare against similar clinics. These types of electronic medical records assist in tracking visual acuity after cataract surgery, for example, or spectacles that have been returned in the optical shop.
Defining the key metrics and confirming you have a system that is properly tracking them can give opportunity for regular (e.g. monthly, quarterly) strategic conversations about the current status and necessary improvements.
- There are groups adding free eye camps and awareness events in Nepal – what are some tips on how they can get the best results?
Dr. Manisha: In a survey sent out via google forms to the Pediatric Ophthalmologists of Nepal (total 40) to find about the status of pre-school vision screening in Nepal, response was obtained from 22 (55%). Out of them 13 (60%) responded that they have conducted the pre school screening, and out of them 10 (77%) said they do it via loose lens retinoscopy by ophthalmic assistants/ optometrist and 3 (23%) responded it was being done by community eye health workers using Snellen’s chart. Everyone responded that vision screening devices for preschool screening had not been used. This shows the gap area for pre-school vision screening in Nepal, traditional way of screening children using loose lens retinoscopy/ snellen’s chart is not feasible for pre-school children (3 to 6 years) and maybe using technology like Spot vision screener or other photoscreener device to detect amblyogenic risk factors in them holds significance.
- As you evaluate technology partners, what are some factors to keep in mind?
Have a look at the blog post from SCEH or we’d love to hear what your ideas are!
Some helpful questions to consider:
- Who owns the source code and/or intellectual property (IP)?
- Who is responsible if there are infringements on someone else’s IP?
- If a technology partner can longer work with you in the future for updates or maintenance, do you have all rights to change partners?
- Who is responsible for acceptance testing? Or bug fixes within the initial use period?
- Have we given a thought on smart phone fundoscopy, which I feel is something we can teach our residents to take fundus images with their own smart phones..
Katie: The AAO has a resource that can be located here: https://eyewiki.org/Smartphone_Funduscopy_-_How_to_Use_Smartphone_to_Take_Fundus_Photographs
There is also a 2024 review article which lists several adapters that can make your smartphone easier to use and offer better image quality. https://www.sciencedirect.com/science/article/pii/S0039625723001327
- Can anyone explain the role of AI in these technologies? Is AI reliable enough to support a trusted diagnosis? And is AI currently integrated into any of the cameras mentioned today?
Katie: AI for retinal imaging is pretty mature, with some applications specific to diabetic retinopathy having regulatory clearance and therefore having proven safety and efficacy. Retinopathy of prematurity has also shown very impressive results. Other conditions (Glaucoma, AMD, opportunistic infections) have fewer options and varying degrees of research. https://www.sciencedirect.com/science/article/pii/S2162098924000975 offers a recent review.
Remidio, for example, does offer a commercial AI feature for their fundus on phone camera but it is focused on specific retinal conditions. So it’s critical to know exactly what the specifications for AI are and that you have adequate coverage to find conditions out of scope for the algorithm use.
It is a developing field. There are already AI-based Retinal imaging tools for diabetic retinopathy screening such as IDx-DR (Digital diagnostics, USA), EyeArt (Eyenuk), among others.


















Leave a Reply